BOCIC(SH:601696) Xin Lang Cai Jing·2025-10-28 06:56Group 1 - The core viewpoint of the news is that Yuan Dong Bio has seen a significant increase in its stock price, rising by 5.47% to 55.30 CNY per share, with a trading volume of 150 million CNY and a turnover rate of 1.58%, leading to a total market capitalization of 9.762 billion CNY [1] - Yuan Dong Bio, established on June 1, 2009, and listed on September 2, 2020, is primarily engaged in the research, production, and sales of chemical raw materials and chemical drug formulations. The revenue composition is as follows: 78.75% from formulation sales, 9.22% from raw material sales, 6.79% from technical services and transfers, 4.01% from CMO/CDMO, and 1.22% from other sources [1] Group 2 - According to data from the top ten holdings of funds, a fund under Bank of China Securities has a significant position in Yuan Dong Bio. The Bank of China Securities Health Industry Mixed Fund (002938) held 146,000 shares in the third quarter, accounting for 5.07% of the fund's net value, ranking as the ninth largest holding. The estimated floating profit today is approximately 419,000 CNY [2] - The Bank of China Securities Health Industry Mixed Fund (002938) was established on September 7, 2016, with a current scale of 159 million CNY. Year-to-date returns are 41.95%, ranking 1861 out of 8155 in its category; the one-year return is 27.34%, ranking 3169 out of 8029; and since inception, the return is 138.44% [2]